Kain Technology announced on May 6, 2024 on the SSE E Interactive that as of April 30, 2024, the number of shareholders of the company was 6,987, a decrease of 1,594 or 18.58% from the previous period (April 19, 2024).
The number of shareholders of Cain Technology is lower than the industry average. According to Choice data, as of April 30, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry was 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%, and Kain Technology is also in the range.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 29, 2024, the number of shareholders of the company has decreased, with a range decrease of 9.02%. From March 29, 2024 to April 30, 2024, the stock price decreased by 7.08%.
Number of shareholders and share price
Number of shareholders and share capital
As of April 30, 2024, the company's latest total share capital is 171 million shares, all of which are outstanding shares. The average number of outstanding shares held by households increased from 19,900 shares in the previous period to 24,500 shares, and the average market value of households was 732,500 yuan.
The average amount of shares held by each household
The average market value of Cain Technology is higher than the industry average. According to Choice data, as of April 30, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 401,400 yuan. Among them, 25.31% of the company's households hold a circulating stock market value in the range of 130,000~250,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.